 |
All clinical trials in Georgia are listed on www.GeorgiaCancerInfo.org
Genentech/Roche Phase III Multi-Center, Randomized Trial Comparing the Efficacy of GA 101 in Combination with CHOP (G-CHOP) versus Rituximab and CHOP (R-CHOP) in Previously Untreated Patients with CD 20-Positive Diffuse Large B-Cell Lymphoma
Principal Investigator |
|
|
Frederick M. Schnell, MD, FACP
Central Georgia Cancer Care |
| |
| Sites |
|
Investigators |
| Central Georgia Cancer Care, Macon |
|
Frederick M. Schnell, MD, FACP |
Gynecologic Oncology Group Studies
(see listings of GOG trials in the research section of www.GeorgiaCancerInfo.org)
|
Principal Investigator
|
Sharad A. Ghamande, MD
Georgia Health Sciences University |
| |
| Sites |
|
Investigators |
| Memorial University Medical Center, Savannah |
|
James J. Burke, II, MD, FACOG, FACS
Scott Purinton, MD, PhD |
| Georgia Health Sciences University, Augusta |
|
Sharad A. Ghamande, MD
Michael MacFee, MD |
| John B. Amos Cancer Center, Columbus |
|
Andrew W. Pippas, MD
John L. Currie, MD |
| Medical Center of Central Georgia, Macon |
|
Ahmad H. Al-Hajj, MD
Bruce T. Burns, MD
Gary L. Eddy, Sr., MD
Amy S. Lucas, MD
Frederick M. Schnell, MD, FACP |
| Northside Hospital Cancer Institute, Atlanta |
|
Guilherme H. Cantuaria, MD, PhD, FACOG
Margarett C. Ellison, MD
John McBroom, MD |
Peregrine Phase II Randomized, Open-Label Trial of Gemcitabine With or Without Bavituximab in Patients with Previously Untreated Stage IV Pancreatic Cancer
|
Principal Investigator
|
Andrew W. Pippas, MD
John B. Amos Cancer Center |
| |
| Sites |
|
Investigators |
| DeKalb Medical Center, Decatur |
|
Jayanthi Srinivasiah, MD |
| John B. Amos Cancer Center, Columbus |
|
Andrew W. Pippas, MD |
| Northeast Georgia Medical Center, Gainesville |
|
Timothy M. Carey, MD |
| Suburban Hematology, Lawrenceville |
|
Christopher Hagenstad, MD |
|
Pfizer A7471009 Phase III Randomized, Double Blind Efficacy and Safety Study of PF-00299804 versus Erlotinib for the Treatment of Advanced Non-Small Cell Lung Cancer Following Progression After, or Intolerance to, At Least One Prior Chemotherapy
|
Principal Investigator
|
Suresh S. Ramalingam, MD
Winship Cancer Institute, Emory University |
| |
| Sites |
|
Investigators |
| DeKalb Medical Center, Decatur |
|
Jayanthi Srinivasiah, MD |
| Georgia Cancer Center for Excellence, Atlanta |
|
Suresh S. Ramalingam, MD |
| Georgia Health Sciences University, Augusta |
|
Zhonglin Hao, MD |
| John B. Amos Cancer Center, Columbus |
|
Andrew W. Pippas, MD |
| Northeast Georgia Medical Center, Gainesville |
|
Timothy M. Carey, MD |
| Northwest Georgia Oncology Centers, Marietta |
|
Robert C. Hermann, MD, FACP |
| Phoebe Putney Memorial Hospital, Albany |
|
Chirag R. Jani, MD |
| Suburban Hematology, Lawrenceville |
|
Christopher Hagenstad, MD |
| Winship Cancer Institute, Atlanta |
|
Suresh S. Ramalingam, MD |
|
For more information, contact Georgia CORE:
Paul Prebble, CA
Contracts and Regulatory Administration
Georgia Center for Oncology Research and Education
50 Hurt Plaza, Suite 704
Atlanta, GA 30303
(404) 588-4082
pprebble@georgiacore.org
|
|
|